Operating income increased 11.2%
Operating income changed +11.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +11.2% from the comparable as-filed period.
Revenue changed +3.3% from the comparable as-filed period.
Net income changed +13.6% from the comparable as-filed period.
Cash & equivalents changed -5.1% from the comparable as-filed period.
Gross profit changed +5.8% from the comparable as-filed period.
Inventory changed -2.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed -4.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.